[{"NetIncomeLoss_1_Q1_USD":-253000000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":23000000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.4859,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":66.36,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":358000000.0,"ExtinguishmentOfDebtAmount_1_Q1_USD":1000000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":40000000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":750000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-87000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":4000000.0,"PaymentsForRestructuring_1_Q1_USD":24000000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-94000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":0.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":18000000.0,"AssetsCurrent_0_Q1_USD":27030000000.0,"RestructuringCharges_1_Q1_USD":37000000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":1137000000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":37350000000.0,"TreasuryStockShares_0_Q1_shares":33000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":15000000.0,"TreasuryStockValue_0_Q1_USD":2022000000.0,"LongTermDebtAndCapitalLeaseObligationsCurrent_0_Q1_USD":12000000.0,"GainLossRelatedToLitigationSettlement_1_Q1_USD":-1038000000.0,"UnrecognizedTaxBenefits_0_Q1_USD":994000000.0,"CommonStockSharesIssued_0_Q1_shares":327000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":0.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":16000000.0,"IncreaseDecreaseInReceivables_1_Q1_USD":388000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":-585000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":3056000000.0,"EarningsPerShareBasic_1_Q1_USD":-0.86,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":398000000.0,"MinorityInterest_0_Q1_USD":3000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":293000000.0,"RestructuringCosts_1_Q1_USD":27000000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":7000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-410000000.0,"NumberOfReportableSegments_1_Q1_segment":2.0,"CommonStockValue_0_Q1_USD":2760000000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":-3000000.0,"Revenues_1_Q1_USD":39065000000.0,"Assets_0_Q1_USD":41727000000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q1_USD":147000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":0.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":5867000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.618,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-198000000.0,"OtherAssetsCurrent_0_Q1_USD":2208000000.0,"IncreaseDecreaseInInventories_1_Q1_USD":245000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-236000000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":313000000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":115000000.0,"OtherAssetsNoncurrent_0_Q1_USD":1142000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":2746000000.0,"Dividends_1_Q1_USD":146000000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":205000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":66.19,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":17000000.0,"ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":329000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":17000000.0,"Goodwill_0_Q1_USD":8375000000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q1_USD":6728000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":12000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":270000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":293000000.0,"LiabilitiesCurrent_0_Q1_USD":24016000000.0,"AccountsPayableCurrent_0_Q1_USD":21688000000.0,"InterestExpense_1_Q1_USD":45000000.0,"SeveranceCosts1_1_Q1_USD":24000000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":2316000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":2811000000.0,"GrossProfit_1_Q1_USD":1715000000.0,"PaymentsOfDividendsCommonStock_1_Q1_USD":146000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":0.0,"AccountsPayableCurrentAndNoncurrent_0_Q1_USD":21700000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":1425000000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":0.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":2788000000.0,"NumberOfOperatingSegments_1_Q1_segment":2.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_1_Q1_USD":-9000000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"ReceivablesNetCurrent_0_Q1_USD":8637000000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2369000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":278000000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.86,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q1_USD":9558000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-25000000.0,"RepaymentsOfNotesPayable_1_Q1_USD":37000000.0,"CommonStockSharesAuthorized_0_Q1_shares":755000000.0,"OperatingIncomeLoss_1_Q1_USD":-624000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-663000000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":0.0,"InventoryNet_0_Q1_USD":13439000000.0,"RestructuringReserve_0_Q1_USD":99000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":5844000000.0,"PreferredStockValue_0_Q1_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":41727000000.0,"ShareBasedCompensation_1_Q1_USD":28000000.0,"PreferredStockSharesAuthorized_0_Q1_shares":500000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":333000000.0,"ProfitLoss_1_Q1_USD":-253000000.0,"StockholdersEquity_0_Q1_USD":1422000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":78000000.0,"ProceedsFromRepaymentsOfShortTermDebt_1_Q1_USD":0.0,"IntangibleAssetsNetIncludingGoodwill_0_Q1_USD":11186000000.0,"GoodwillTransfers_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":5000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":5000000.0,"DebtLongtermAndShorttermCombinedAmount_0_Q1_USD":6700000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1_Q1_USD":5000000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":771000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":28000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-236000000.0,"Ticker":"CAH","CIK":"721371","name":"CARDINAL HEALTH INC","OfficialName":"Cardinal Health Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"17377290506.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20201105"}]